Wolverine Asset Management
IMCR icon

Wolverine Asset Management’s Immunocore IMCR Stock Holding History

Wolverine Asset Management’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-2,822
Closed -$89.6K – 1810
2026
Q2 		$89.6K Buy
+2,822
New +$83.5K ﹤0.01% 1179
2024
Q4 		– Sell
-18,922
Closed -$598K – 1711
2024
Q3 		$589K Buy
+18,922
New +$688K 0.01% 823

Other funds holding IMCR

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Fulcrum Asset Management
Fulcrum Asset Management London, United Kingdom $2.14B AUM 54.66% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Commonwealth of Pennsylvania Public School Employees Retirement System
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $21.9B AUM 28.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Wolverine Asset Management's IMCR Position: Q3 2026 in Review

Wolverine Asset Management sold out of Immunocore (IMCR) in Q3 2026, closing a stake of 2,822 shares — an estimated $89.6K sold.

Wolverine Asset Management first reported a position in IMCR in Q3 2024 and held it in 2 quarters. The position peaked at $589K in Q3 2024. 39 funds tracked by Wall St. Rank hold IMCR as of Q3 2026.

  • Wolverine Asset Management reported no remaining Immunocore position as of Q3 2026 after selling out during the quarter.
  • Wolverine Asset Management sold 2,822 Immunocore shares in Q3 2026, an estimated $89.6K.
  • Wolverine Asset Management first reported a position in Immunocore in Q3 2024 and held it in 2 quarters.
  • Wolverine Asset Management's Immunocore position peaked at $589K in Q3 2024.
  • 39 funds tracked by Wall St. Rank held Immunocore as of Q3 2026.

Based on Wolverine Asset Management's 13F filing for Q3 2026, filed 2 Nov 2026.